In ovarian cancer, CIB2 has been shown to operate as a possible tumor suppressor by decreasing tumor development and cell migration/invasion, therefore reduced CIB2 levels have been linked to a poor prognosis in patients [26]. This evidence concerns the gene CIB2 and neoplasm.